Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:
- pharmaceutical products (82.6%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders (insomnia, multiple sclerosis, epilepsy), cancers, allergies, etc. Moreover, Sanofi-Aventis markets OTC products and generic drugs;
- human vaccines (11.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;
- veterinary products (6.2%).
At the end of 2012, the group had 112 production sites throughout the world.
Net sales are distributed geographically as follows: France (8.1%), Europe (23.5%), the United States (31.8%), and other (37.3%).